BDBM50142951 4-[3-({[2,4-Dichloro-3-(4-imidazol-1-yl-2-methyl-quinolin-8-yloxymethyl)-phenyl]-methyl-carbamoyl}-methyl)-ureido]-N-pyridin-4-yl-benzamide; trihydrochloride::CHEMBL542598
SMILES: CN(C(=O)CNC(=O)Nc1ccc(cc1)C(=O)Nc1ccncc1)c1ccc(Cl)c(COc2cccc3c(cc(C)nc23)-n2ccnc2)c1Cl
InChI Key: InChIKey=QGYHWLVUEIIIEA-UHFFFAOYSA-N
Data: 2 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BDKRB2 (Homo sapiens (Human)) | BDBM50142951 (4-[3-({[2,4-Dichloro-3-(4-imidazol-1-yl-2-methyl-q...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 6.60 | n/a | n/a | n/a | n/a | n/a | n/a |
Fujisawa Pharmaceutical Co. Ltd. Curated by ChEMBL | Assay Description In vitro inhibitory activity towards bradykinin receptor B2 using [3H]BK (0.06 nM) as a radioligand in guinea pig ileum membrane preparation | J Med Chem 47: 1617-30 (2004) Article DOI: 10.1021/jm030159x BindingDB Entry DOI: 10.7270/Q2P55P89 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
BDKRB2 (Homo sapiens (Human)) | BDBM50142951 (4-[3-({[2,4-Dichloro-3-(4-imidazol-1-yl-2-methyl-q...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | 0.230 | n/a | n/a | n/a | n/a | n/a | n/a |
Fujisawa Pharmaceutical Co. Ltd. Curated by ChEMBL | Assay Description In vitro inhibitory activity towards human bradykinin receptor B2 expressed in CHO cells using [3H]BK (1.0 nM) as a radioligand | J Med Chem 47: 1617-30 (2004) Article DOI: 10.1021/jm030159x BindingDB Entry DOI: 10.7270/Q2P55P89 | |||||||||||
More data for this Ligand-Target Pair |